Contact
Please use this form to send email to PR contact of this press release:
Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs
TO:
Please use this form to send email to PR contact of this press release:
Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs
TO: